Hot Casino Stocks To Buy For 2021

HDFC Securities’ research report on Indraprastha Gas

IGL’s  4QFY18  revenue came in at Rs 12.33bn, up 23.1% YoY led by 11.3% YoY increase  in volumes to 5.36mmscmd and 10.5% YoY increase in realisation to Rs  25.6/scm.  EBITDA  stood at Rs 2.91bn up 26.9% YoY on account of higher gross margin, up 33bps. APAT came in at Rs 1.75 (+30.3% YoY).  We  expect  the  volume growth momentum to continue for the company as, (1) State  government  has  accepted the proposal to procure 2,000 new buses in FY19,  and  (2) Expansion of its pipeline network in the new areas- Karnal, Rewari and part of Gurugram will add volumes from 2HFY19 onwards.

Outlook

Our SOTP target is Rs 422/sh (30x  FY20E standalone core EPS + 25x CUGL/MNGL EPS share to IGL). Maintain BUY.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Hot Casino Stocks To Buy For 2021: Flanigan’s Enterprises Inc.(BDL)

Flanigan’s Enterprises, Inc. operates a chain of full-service restaurants and package liquor stores in south Florida. It operates restaurants under Flanigan?s Seafood Bar and Grill name, which offers alcoholic beverages and full food services; and package liquor stores under Big Daddy?s Liquors name that provides brand name and private label liquors, beer, and wines. As of April 2, 2011, the company operated 24 units that consists of restaurants, package liquor stores, and combination restaurants/package liquor stores; 1 adult entertainment club; and franchised 5 units comprising 1 restaurant and 4 combination restaurants/package liquor stores. Flanigan’s Enterprises, Inc. was founded in 1959 and is headquartered in Fort Lauderdale, Florida.

Advisors’ Opinion:

  • [By Logan Wallace]

    Separately, TheStreet lowered shares of Flanigan’s Enterprises from a “b-” rating to a “c+” rating in a report on Thursday, January 31st.

    TRADEMARK VIOLATION WARNING: “Flanigan’s Enterprises, Inc. (BDL) to Issue Annual Dividend of $0.28” was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at www.tickerreport.com/banking-finance/4181662/flanigans-enterprises-inc-bdl-to-issue-annual-dividend-of-0-28.html.

    Flanigan’s Enterprises Company Profile

  • [By Peter Graham]

    Small cap Flanigan’s Enterprises (NYSEAMERICAN: BDL) is considered a “beloved” South Florida institution since 1959 welcoming locals and visitors for over 50 years with a portfolio primarily focused on a collection of family-run restaurants, Flanigan’s Seafood Bar And Grill, and retail liquor stores, Big Daddy’s Wine and Liquors. As of September 29, 2018, Flanigan’s Enterprises (i) operated 26 units consisting of restaurants, package liquor stores and combination restaurants/package liquor stores that the Company either owns or has operational control over and partial ownership in; and (ii) franchised an additional five units, consisting of two restaurants, (one of which they operate) and three combination restaurants/package liquor stores (These figures exclude an adult entertainment club which the Company owned but did not operate and was permanently closed on September 20, 2018 when a Federal Court upheld recently enacted legislation prohibiting the operation of the club as then operated). A Form 10-K noted:

Hot Casino Stocks To Buy For 2021: Iteris, Inc.(ITI)

Iteris, Inc. provides intelligent information solutions to the traffic management market worldwide. It operates in three segments: Roadway Sensors, Transportation Systems, and Performance Analytics. The Roadway Sensors segment offers a range of vehicle detection systems for traffic intersection control, incident detection, and roadway traffic data collection applications. Its products include Vantage video detection system to detect vehicle presence at intersections; VantageView software to manage video detection assets remotely; Vantage Vector vehicle detection sensor with stop bar detection, advanced-zone detection, and sensing capabilities; SmartCycle for differentiating bicycles and other vehicles; and VersiCam integrated camera and processor video detection system for smaller intersections, as well as SmartSpan, Velocity, P10, P100, and Abacus products. The Transportation Systems segment offers transportation engineering and consulting services with a focus on the planning, design, development, and implementation of software-based systems that integrate sensors, video surveillance systems, computers, and communications equipment to enable public agencies to monitor, control, and direct traffic flow; assist in the dispatch of emergency crews; and distribute real-time information about traffic conditions. The Performance Analytics segment provides iPeMS, a specialized transportation performance measurement and traffic analytics solution; ClearPath Weather management tools that allow users to create solutions to meet roadway maintenance decision needs; and ClearAg, a precision agriculture solution. The company sells its services to federal, state, and local government agencies. Iteris, Inc. was founded in 1969 and is headquartered in Santa Ana, California.

Advisors’ Opinion:

  • [By Ethan Ryder]

    iTicoin (CURRENCY:ITI) traded flat against the dollar during the 1 day period ending at 19:00 PM ET on March 8th. iTicoin has a market capitalization of $50,828.00 and approximately $0.00 worth of iTicoin was traded on exchanges in the last day. One iTicoin coin can now be purchased for about $1.59 or 0.00043403 BTC on cryptocurrency exchanges including Cryptopia and BTC-Alpha. During the last seven days, iTicoin has traded flat against the dollar.

  • [By Ethan Ryder]

    Iteris Inc (NASDAQ:ITI) has received an average recommendation of “Buy” from the six analysts that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among analysts that have covered the stock in the last year is $9.50.

  • [By Stephan Byrd]

    Iteris (NASDAQ: ITI) and UTStarcom (NASDAQ:UTSI) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability and analyst recommendations.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Iteris (ITI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Casino Stocks To Buy For 2021: Advanced Drainage Systems, Inc.(WMS)

Advanced Drainage Systems, Inc., incorporated on October 31, 1966, designs, manufactures and markets thermoplastic corrugated pipe and related water management products, primarily in North and South America and Europe. The Company operates through two segments: Domestic and International. Its product line includes corrugated high density polyethylene (HDPE) pipe, polypropylene (PP) pipe and related water management products. The Company’s product categories include pipe, fittings, Nyloplast drainage structures, StormTech chambers, water quality, onsite leaching systems, geosynthetics/geogrids erosion control and concrete structures.

The Company’s products in pipe category includes N-12, SaniTite HP, HP Storm, MEGA GREEN WT, MEGA GREEN ST, ADS Triple Wall/Smoothwall, ADS PolyFlex, Duraslot, AdvanEdge and Bend-A-Drain. Its products in fittings category includes single wall fittings, including couplers, elbows and wyes, tees and cross tees, and caps and plugs; dual wall fittings, including couplers, end caps and end plugs, bends, wyes, tees, reducers, injection molded fittings and manifolds; Inserta Tee, and Bend-A-Drain, including ADS Expandable Downspout Adapter. Its products in water quality category includes BaySeparator, BayFilter and FLEXSTORM. Its products in onsite leaching systems category includes ARC Chambers, BioDiffuser Chamber, SB2, Septic Stack Systems, related onsite drainage products and ADS perimeter drain products. Its products in geosynthetics/geogrids erosion control category includes Geotextiles, Geogrids, silt fence and erosion control. Its products in concrete structures include Foltz Concrete.

The Company offers its products to a range of markets and applications, including non-residential, residential, agriculture, airports, green building/sustainable infrastructure, home/yard/building drainage, inlet structures, landfill/waste disposal management, low head pipe, mining, onsite septic systems, railway, retention/detention systems, sanitary, storm water ! drainage, street and highway drainage, timber, turf and recreation, and water quality.

Domestic

The Company’s Domestic segment manufactures and markets products throughout the United States. The Company maintains and serves these markets through product distribution relationships with various national and independent waterworks distributors, national retailers, as well as a network of small to medium-sized distributors across the country. It also sells through a range of buying groups and co-ops in the United States. Its products in this segment include Singlewall pipe, N-12 HDPE pipe sold into the Storm sewer and infrastructure markets, N-12 PP pipe sold into the Storm sewer and sanitary sewer markets, and its line of allied products, including Stormtech, Nyloplast, Arc Septic Chambers, Inserta Tee, Baysaver filters and water quality structures, Fittings, and FleXstorm.

International

The Company’s International segment manufactures and markets products in regions outside of the United States with focus on its facilities in Canada and through its joint ventures, and with local partners in Mexico, Central America and South America. The Company’s joint venture strategy provides with local and regional access to new markets, such as Brazil, Chile, Argentina, Peru and Colombia. Its product line includes Singlewall pipe, N-12 HDPE pipe and N-12 PP pipe. The Canadian market also sells its line of allied products, while sales in Latin America includes fittings and Nyloplast.

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Booz Allen Hamilton Holding Corporation (NYSE: BAH) is estimated to report quarterly earnings at $0.46 per share on revenue of $1.67 billion.
    Momo Inc. (NASDAQ: MOMO) is projected to report quarterly earnings at $0.5 per share on revenue of $396.17 million.
    Multi-Color Corporation (NASDAQ: LABL) is expected to report quarterly earnings at $1.06 per share on revenue of $424.96 million.
    American Woodmark Corporation (NASDAQ: AMWD) is estimated to report quarterly earnings at $1.15 per share on revenue of $382.4 million.
    The Bank of Nova Scotia (NYSE: BNS) is projected to report quarterly earnings at $1.32 per share on revenue of $5.46 billion.
    Jianpu Technology Inc. (NYSE: JT) is expected to report quarterly loss at $0.04 per share on revenue of $47.51 million.
    Trans World Entertainment Corporation (NASDAQ: TWMC) is estimated to report earnings for its first quarter.
    Advanced Drainage Systems, Inc. (NYSE: WMS) is estimated to report quarterly loss at $0.06 per share on revenue of $249.44 million.
    Quotient Limited (NASDAQ: QTNT) is expected to report quarterly loss at $0.48 per share on revenue of $5.73 million.
    Elbit Systems Ltd. (NASDAQ: ESLT) is projected to report earnings for its first quarter.
    Evogene Ltd. (NASDAQ: EVGN) is expected to report earnings for its first quarter.

     

Hot Casino Stocks To Buy For 2021: L'Oréal S.A. (LRLCY)

L’Oreal SA is a France-based holding company. The Company, through its subsidiaries, develops the business activities of the L’Oreal Group (Group) in the country or region in which they are located. The Group creates and develops cosmetic products. The Company’s segments are Professional Products, Consumer Products, L’Oreal Luxe and Active Cosmetics. The Professional Products division includes products used and sold in hair salons and beauty institutes. The Consumer Products division includes products sold in mass-market retail channels. L’Oreal Luxe division’s products are sold in various retail outlets, such as department stores, perfumeries, travel retail, the Company’s boutiques and online sites. The Active Cosmetics division includes dermocosmetics products sold through various health channels, such as pharmacies, parapharmacies, drugstores and medispas. The Active Cosmetics division offers brands, including Vichy and SkinCeuticals. It operates through IT Cosmetics LLC.
Advisors’ Opinion:

  • [By Max Byerly]

    L OREAL Co/ADR (OTCMKTS:LRLCY) was downgraded by Berenberg Bank from a “hold” rating to a “sell” rating in a report released on Thursday, The Fly reports.

  • [By Shane Hupp]

    Deutsche Bank cut shares of L OREAL Co/ADR (OTCMKTS:LRLCY) from a buy rating to a hold rating in a report released on Friday morning, The Fly reports.

Hot Casino Stocks To Buy For 2021: Ascendis Pharma A/S(ASND)

Ascendis Pharma A/S, incorporated on October 21, 2006, is a clinical-stage biopharmaceutical company. The Company is engaged in applying its TransCon technology to develop a pipeline of long-acting prodrug therapies that address markets with unmet medical needs. The Company is developing its product candidate, TransCon human growth hormone (TransCon hGH) for once-weekly administration to treat growth hormone deficiency (GHD) and other indications. In addition to TransCon hGH, the Company has developed a pipeline of long-acting prodrug product candidates, such as TransCon Treprostinil for the treatment of pulmonary arterial hypertension (PAH), TransCon Peptides for the treatment of diabetes and TransCon Ranibizumab for the treatment of ophthalmology. The Company’s subsidiaries include Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma, Osteoarthritis Division A/S (Denmark) and Ascendis Pharma, and Circulatory Diseases Division A/S (Denmark).

TransCon human Growth Hormone

The Company is developing TransCon hGH as a prodrug with once-weekly administration that releases unmodified growth hormone, maintaining the same mode of action as daily hGH therapies. Clinical studies of TransCon hGH have demonstrated a comparable immunogenic profile to that of daily growth hormone. The Company has completed a Phase II study of TransCon hGH in adults with GHD and is conducting a six-month Phase II study in children with GHD. In the Phase II study, the Company is measuring height velocity, an efficacy measure that refers to the mean height change of the individuals in a group over a specified time period. In addition, the Company is developing a pen device with Bang & Olufsen Medicom A/S for administration of TransCon hGH that is designed for the pediatric population.

TransCon Treprostinil

The Company is developing! TransCon Treprostinil as a once-daily self-administered subcutaneous injection of treprostinil for the treatment of PAH, a disease characterized by elevated blood pressure in the pulmonary arteries. The Company is applying its TransCon technology to develop TransCon Treprostinil to be given as a once-daily injection rather than as continuously infused therapy. The Company initiated a Phase I clinical proof-of-concept study of TransCon Treprostinil.

TransCon Peptide

TransCon Peptide is indicated for the treatment of diabetes. The Company is conducting preclinical studies to evaluate the various TransCon prodrug candidates for the treatment of diabetes.

TransCon Ranibizumab

The Company along with its collaboration partner, Genentech, is developing TransCon Ranibizumab, for treatment of ophthalmic diseases. TransCon Ranibizumab is a compound designed to support up to half-yearly injection of ranibizumab, the active agent in Genentech’s Lucentis (ranibizumab injection). Lucentis belongs to a class of drug therapies known as anti-vascular endothelial growth factor (anti-VEGF) treatments, which require periodic intravitreal injections. Lucentis is indicated for neovascular wet age-related macular degeneration, macular edema following retinal vein occlusion and diabetic macular edema.

The Company competes with Bioton S.A., Critical Pharmaceuticals, Ltd., Dong-A Pharmaceutical, GeneScience Pharmaceuticals Co., Ltd., Genexine Inc., Hanmi Pharmaceuticals Co., Ltd., Novo Nordisk A/S, OPKO Health, Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd. and Versartis, Inc.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Ascendis Pharma A/S  (NASDAQ:ASND)Q4 2018 Earnings Conference CallApril 03, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Dan Caplinger]

    The stock market lost ground on Monday, as investors appeared to have second thoughts about the future of the U.S. economy even as trade negotiations with China appear to be going well. The Dow Jones Industrial Average had been down by more than 400 points earlier in the session before recovering to finish lower by just 207, and broader benchmarks saw more modest declines on a percentage basis. Even amid the carnage, there was some good news for certain companies. Washington Real Estate Investment Trust (NYSE:WRE), Ascendis Pharma (NASDAQ:ASND), and Bluegreen Vacations (NYSE:BXG) were among the top performers. Here’s why they did so well.

  • [By Cory Renauer]

    Shares of Ascendis Pharma (NASDAQ:ASND), a biopharmaceutical company committed to extended-release technology, are soaring after the company released pivotal trial results for its lead candidate. Investors expecting blockbuster sales have pushed the stock 58.8% higher as of 12:04 p.m. EST on Monday. 

Hot Casino Stocks To Buy For 2021: Black Hills Corporation(BKH)

Black Hills Corporation, through its subsidiaries, operates as a diversified energy company in the United States. The company’s Electric Utilities segment generates, transmits, and distributes electricity to approximately 207,200 electric customers in South Dakota, Wyoming, Colorado, and Montana; and distributes natural gas to approximately 44,200 gas utility customers in Cheyenne, Wyoming. This segment owns 841 megawatts of generation capacity and 8,703 miles of electric transmission and distribution lines. Its Gas Utilities segment distributes natural gas to approximately 547,300 natural gas utility customers in Colorado, Nebraska, Iowa, and Kansas. This segment owns 645 miles of intrastate gas transmission pipelines and 19,494 miles of gas distribution mains and service lines. The company’s Power Generation segment produces electric power and sells the electric capacity and energy primarily to its utilities under long-term contracts. Its Coal Mining segment produces coal at its coal mine located near Gillette, Wyoming and sells the coal to electric generation facilities. The company’s Oil and Gas segment explores, develops, and produces crude oil and natural gas primarily in the Rocky Mountain region. This segment’s principal assets include the operating interests in the properties in the San Juan basin, the Powder River basin, and the Piceance basin; and non-operated interests in wells located in various states. As of December 31, 2015, it had total reserves of approximately 105 billion cubic feet equivalent of natural gas, crude oil, and natural gas liquids. Black Hills Corporation also provides appliance repair services to approximately 64,000 residential customers; and constructs gas infrastructure facilities and electrical systems for gas transportation and electric utilities customers. The company was founded in 1941 and is headquartered in Rapid City, South Dakota.

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    Black Hills (NYSE:BKH) Q4 2018 Earnings Conference CallFeb. 8, 2019 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Black Hills (BKH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Shares of Black Hills Corp (NYSE:BKH) have earned a consensus rating of “Hold” from the eight ratings firms that are covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $59.50.

Leave a Reply

Your email address will not be published. Required fields are marked *